Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis
Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR)
Ralf Zahn, MD*,
Rudolf Schiele, MD*,
Steffen Schneider, PhD*,
Anselm K. Gitt, MD*,
Harm Wienbergen, MD*,
Karlheinz Seidl, MD*,
Claus Bossaller, MD ,
Heinz J. Büttner, MD ,
Martin Gottwik, MD ,
Ernst Altmann, MD||,
Werner Rosahl, MD¶,
Jochen Senges, MD, FACC* for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and the Myocardial Infarction Registry (MIR) Study Groups
* Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
the Robert Koch Krankenhaus, Gehrden, Germany
the Herzzentrum, Bad Krozingen, Germany
the Städtisches Klinikum, Nürnberg, Germany
|| the Klinikum Friedrichstadt, Dresden, Germany
¶ the Städtisches Klinikum, Dessau, Germany

View larger version (27K):
[in a new window]
|
Figure 1 Hospital mortality in patients treated with primary angioplasty or thrombolysis from 1994 to 1998.
|
|

View larger version (18K):
[in a new window]
|
Figure 2 Multiple logistic regression analysis of hospital mortality comparing primary angioplasty with thrombolysis.
|
|

View larger version (19K):
[in a new window]
|
Figure 3 Multiple logistic regression analysis of the combined end point of death or reinfarction comparing primary angioplasty with thrombolysis.
|
|
|